These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 7879019

  • 1. Concentration-controlled immunosuppressive regimens using cyclosporine with sirolimus or brequinar in human renal transplantation.
    Kahan BD.
    Transplant Proc; 1995 Feb; 27(1):33-6. PubMed ID: 7879019
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
    Stepkowski SM, Tu Y, Chou TC, Kahan BD.
    Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Brequinar sodium effectively and potently suppresses allograft rejection in a heterotopic mouse heart transplant model.
    Murphy MP, Morris RE.
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):75-6. PubMed ID: 7685955
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.
    Brattström C, Tydén G, Säwe J, Herlenius G, Claesson K, Groth CG.
    Transplant Proc; 1996 Apr; 28(2):985-6. PubMed ID: 8623489
    [No Abstract] [Full Text] [Related]

  • 8. Rapamycin in a porcine renal transplant model.
    Almond PS, Moss A, Nakhleh R, Melin M, Chen S, Salazar A, Shirabe K, Matas A.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
    [No Abstract] [Full Text] [Related]

  • 9. Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin.
    Robertson A, Plenter R, Francis DM, Clunie GJ.
    Transplant Proc; 1993 Oct; 25(5):2898-9. PubMed ID: 8212279
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synergistic effects of cyclosporin analogs--A, D, G, IMM-125--with rapamycin and/or brequinar.
    Kahan BD, Chou T, Tejpal N, Wang M, Chee C, Stepkowski S.
    Transplant Proc; 1994 Oct; 26(5):3021-4. PubMed ID: 7940951
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
    Stepkowski SM, Kahan BD.
    Transplant Proc; 1991 Dec; 23(6):3262-4. PubMed ID: 1750091
    [No Abstract] [Full Text] [Related]

  • 14. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.
    Cosenza CA, Cramer DV, Tuso PJ, Chapman FA, Wang HK, Makowka L.
    J Heart Lung Transplant; 1994 Dec; 13(3):489-97. PubMed ID: 8061026
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Concentration control: a key to phase I development of immunosuppressive agents.
    Kahan BD.
    Transplant Proc; 1994 Dec; 26(6):3203-4. PubMed ID: 7998116
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sirolimus: a new agent for clinical renal transplantation.
    Kahan BD.
    Transplant Proc; 1997 Dec; 29(1-2):48-50. PubMed ID: 9123092
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.